Dianthus Therapeutics (DNTH) Change in Cash (2017 - 2025)

Dianthus Therapeutics' Change in Cash history runs 9 years deep, the most recent figure standing at $42.7 million for Q3 2025.

• In Q3 2025, Change in Cash rose 115.23% year-over-year to $42.7 million; the TTM figure through Sep 2025 stood at $22.3 million (up 118.02% YoY), while the FY2024 annual figure was -$109.4 million, down 193.5% from the prior year.
• Change in Cash was $42.7 million for Q3 2025 at Dianthus Therapeutics, up from $3.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $197.4 million in Q1 2024 to a low of -$280.3 million in Q3 2024.
• Historically, Change in Cash has averaged $6.4 million across 5 years, with a median of -$8.9 million in 2021.
• Biggest YoY gain for Change in Cash was 4136.37% in 2022; the steepest drop was 575.67% in 2022.
• A 5-year view of Change in Cash shows it stood at -$25.9 million in 2021, then increased by 16.89% to -$21.5 million in 2022, then slipped by 15.99% to -$25.0 million in 2023, then surged by 56.41% to -$10.9 million in 2024, then surged by 492.38% to $42.7 million in 2025.
• The last three Change in Cash figures came in at $42.7 million (Q3 2025), $3.1 million (Q2 2025), and -$12.7 million (Q1 2025), per Business Quant data.